BASELINE DEMOGRAPHICS AND CLINICAL CHARACTERISTICS FROM A PROSPECTIVE, RANDOMIZED, OPEN-LABEL STUDY OF PALIPERIDONE PALMITATE LONG-ACTING INJECTION IN SUBJECTS WITH RECENT-ONSET SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER

被引：0
|
作者：
Brown, Brianne [1 ]
Turkoz, Ibrahim [2 ]
Yue, Yong [1 ]
Alphs, Larry [1 ]
机构：
[1] Janssen Sci Affairs LLC, Titusville, NJ USA
[2] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
SCHIZOPHRENIA BULLETIN | 2017年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
SA.12
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [31] Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
    Larry Alphs
    Cynthia A Bossie
    Jennifer K Sliwa
    Yi-Wen Ma
    Norris Turner
    Annals of General Psychiatry, 10
  • [32] A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
    Anand, Ernie
    Berggren, Lovisa
    Deix, Claudia
    Toth, Agoston
    McDonnell, David P.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1349 - 1357
  • [33] Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study
    Meghan E. Jones
    Jeffrey S. Andrews
    Douglas E. Faries
    John Landry
    Jenny Xu
    Holland C. Detke
    Rashna Chhabra-Khanna
    David P. McDonnell
    BMC Psychiatry, 15
  • [34] Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study
    Jones, Meghan E.
    Andrews, Jeffrey S.
    Faries, Douglas E.
    Landry, John
    Xu, Jenny
    Detke, Holland C.
    Chhabra-Khanna, Rashna
    McDonnell, David P.
    BMC PSYCHIATRY, 2015, 15
  • [35] Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
    Schreiner, Andreas
    Caspi, Asaf
    Bergmans, Paul
    Cherubin, Pierre
    Keim, Sofia
    Lara, Elsa
    Pinchuk, Irina
    Schuepbach, Daniel
    Suleman, Sajid
    Hargarter, Ludger
    PSYCHOPHARMACOLOGY, 2017, 234 (01) : 3 - 13
  • [36] Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
    Andreas Schreiner
    Asaf Caspi
    Paul Bergmans
    Pierre Cherubin
    Sofia Keim
    Elsa Lara
    Irina Pinchuk
    Daniel Schuepbach
    Sajid Suleman
    Ludger Hargarter
    Psychopharmacology, 2017, 234 : 3 - 13
  • [37] Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial (vol 35, pg 2367, 2010)
    Gaebel, Wolfgang
    Schreiner, Andreas
    Bergmans, Paul
    de Arce, Rosario
    Rouillon, Frederic
    Cordes, Joachim
    Eriksson, Lars
    Smeraldi, Enrico
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (02) : 548 - 548
  • [38] Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia
    Mitchell, Malcolm
    Kothare, Prajakti
    Bergstrom, Richard
    Zhao, Fangyi
    Jen, Kai Yu
    Walker, Daniel
    Johnson, Jason
    McDonnell, David
    CLINICAL THERAPEUTICS, 2013, 35 (12) : 1890 - 1908
  • [39] EFFECTIVENESS OF 300MG/4WEEKS OLANZAPINE LONG-ACTING INJECTION FROM DATA MINING OF AN OPEN-LABEL EXTENSION STUDY
    Dyachkova, Yulia
    Barraco, Alessandra
    Toth, Agoston
    Anand, Hemant
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 264 - 265
  • [40] Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics
    Wang, Chencai
    Tishler, Todd A.
    Oughourlian, Talia
    Nuechterlein, Keith H.
    de la Fuente-Sandoval, Camilo
    Ellingson, Benjamin M.
    SCHIZOPHRENIA RESEARCH, 2023, 255 : 222 - 232
12345